REPORT ID 6943

United States Preventable Vaccines Market Report 2019

Publish Date
2019
Pages
119
Format
Electronic (PDF)

In this report, the United States Preventable Vaccines market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Preventable Vaccines in these regions, from   2019 to 2025 (forecast).

United States Preventable Vaccines market competition by top manufacturers/players, with Preventable Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    GlaxoSmithKline
    Merck
    Novartis
    Pfizer
    Sanofi
    Takeda Pharmaceutical
    Abbott
    Roche
    AstraZeneca
    Mitsubishi Tanabe Pharma
    Lupin
    Serum Institute of India
    LG Life Sciences
    S K Chemicals
    Shenzhen Kangtai Biological Products
    Sinovac Biotech
    Janssen Pharmaceuticals
    Crucell
    Bavarian Nordic
    Baxter
    Bharat Biotech
    Dynavax
    Valeant Pharmaceuticals
    Protein Sciences
    Panacea Biotec

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Adult Preventable Vaccines
    Pediatric Preventable Vaccines
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Bacterial Diseases
    Virus Diseases

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Preventable Vaccines Market  Report 2019
1 Preventable Vaccines Overview
    1.1 Product Overview and Scope of Preventable Vaccines
    1.2 Classification of Preventable Vaccines by Product Category
        1.2.1 United States Preventable Vaccines Market Size (Sales Volume) Comparison by Type ( 2014-2024)
        1.2.2 United States Preventable Vaccines Market Size (Sales Volume) Market Share by Type (Product Category)  in 2018
        1.2.3 Adult Preventable Vaccines
        1.2.4 Pediatric Preventable Vaccines
    1.3 United States Preventable Vaccines Market by Application/End Users
        1.3.1 United States Preventable Vaccines Market Size (Consumption) and Market Share Comparison by Application ( 2014-2024)
        1.3.2 Bacterial Diseases
        1.3.3 Virus Diseases
    1.4 United States Preventable Vaccines Market by Region
        1.4.1 United States Preventable Vaccines Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 The West Preventable Vaccines Status and Prospect ( 2014-2024)
        1.4.3 Southwest Preventable Vaccines Status and Prospect ( 2014-2024)
        1.4.4 The Middle Atlantic Preventable Vaccines Status and Prospect ( 2014-2024)
        1.4.5 New England Preventable Vaccines Status and Prospect ( 2014-2024)
        1.4.6 The South Preventable Vaccines Status and Prospect ( 2014-2024)
        1.4.7 The Midwest Preventable Vaccines Status and Prospect ( 2014-2024)
    1.5 United States Market Size (Value and Volume) of Preventable Vaccines ( 2014-2024)
        1.5.1 United States Preventable Vaccines Sales and Growth Rate ( 2014-2024)
        1.5.2 United States Preventable Vaccines Revenue and Growth Rate ( 2014-2024)

2 United States Preventable Vaccines Market Competition by Players/Suppliers
    2.1 United States Preventable Vaccines Sales and Market Share of Key Players/Suppliers ( 2014-2019)
    2.2 United States Preventable Vaccines Revenue and Share by Players/Suppliers ( 2014-2019)
    2.3 United States Preventable Vaccines Average Price by Players/Suppliers ( 2014-2019)
    2.4 United States Preventable Vaccines Market Competitive Situation and Trends
        2.4.1 United States Preventable Vaccines Market Concentration Rate
        2.4.2 United States Preventable Vaccines Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Preventable Vaccines Manufacturing Base Distribution, Sales Area, Product Type

3 United States Preventable Vaccines Sales (Volume) and Revenue (Value) by Region ( 2014-2019)
    3.1 United States Preventable Vaccines Sales and Market Share by Region ( 2014-2019)
    3.2 United States Preventable Vaccines Revenue and Market Share by Region ( 2014-2019)
    3.3 United States Preventable Vaccines Price by Region ( 2014-2019)

4 United States Preventable Vaccines Sales (Volume) and Revenue (Value) by Type (Product Category) ( 2014-2019)
    4.1 United States Preventable Vaccines Sales and Market Share by Type (Product Category) ( 2014-2019)
    4.2 United States Preventable Vaccines Revenue and Market Share by Type ( 2014-2019)
    4.3 United States Preventable Vaccines Price by Type ( 2014-2019)
    4.4 United States Preventable Vaccines Sales Growth Rate by Type ( 2014-2019)

5 United States Preventable Vaccines Sales (Volume) by Application ( 2014-2019)
    5.1 United States Preventable Vaccines Sales and Market Share by Application ( 2014-2019)
    5.2 United States Preventable Vaccines Sales Growth Rate by Application ( 2014-2019)
    5.3 Market Drivers and Opportunities

6  United States Preventable Vaccines Players/Suppliers Profiles and Sales Data
    6.1 GlaxoSmithKline
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Preventable Vaccines Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 GlaxoSmithKline Preventable Vaccines Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.1.4 Main Business/Business Overview
    6.2 Merck
        6.2.2 Preventable Vaccines Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Merck Preventable Vaccines Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.2.4 Main Business/Business Overview
    6.3 Novartis
        6.3.2 Preventable Vaccines Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Novartis Preventable Vaccines Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.3.4 Main Business/Business Overview
    6.4 Pfizer
        6.4.2 Preventable Vaccines Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Pfizer Preventable Vaccines Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.4.4 Main Business/Business Overview
    6.5 Sanofi
        6.5.2 Preventable Vaccines Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Sanofi Preventable Vaccines Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.5.4 Main Business/Business Overview
    6.6 Takeda Pharmaceutical
        6.6.2 Preventable Vaccines Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Takeda Pharmaceutical Preventable Vaccines Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.6.4 Main Business/Business Overview
    6.7 Abbott
        6.7.2 Preventable Vaccines Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Abbott Preventable Vaccines Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.7.4 Main Business/Business Overview
    6.8 Roche
        6.8.2 Preventable Vaccines Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Roche Preventable Vaccines Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.8.4 Main Business/Business Overview
    6.9 AstraZeneca
        6.9.2 Preventable Vaccines Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 AstraZeneca Preventable Vaccines Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.9.4 Main Business/Business Overview
    6.10 Mitsubishi Tanabe Pharma
        6.10.2 Preventable Vaccines Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Mitsubishi Tanabe Pharma Preventable Vaccines Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.10.4 Main Business/Business Overview
    6.11 Lupin
    6.12 Serum Institute of India
    6.13 LG Life Sciences
    6.14 S K Chemicals
    6.15 Shenzhen Kangtai Biological Products
    6.16 Sinovac Biotech
    6.17 Janssen Pharmaceuticals
    6.18 Crucell
    6.19 Bavarian Nordic
    6.20 Baxter
    6.21 Bharat Biotech
    6.22 Dynavax
    6.23 Valeant Pharmaceuticals
    6.24 Protein Sciences
    6.25 Panacea Biotec

7 Preventable Vaccines Manufacturing Cost Analysis
    7.1 Preventable Vaccines Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Preventable Vaccines

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Preventable Vaccines Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Preventable Vaccines Major Manufacturers  in 2018
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Preventable Vaccines Market Size (Value and Volume) Forecast ( 2019-2025)
    11.1 United States Preventable Vaccines Sales Volume, Revenue Forecast ( 2019-2025)
    11.2 United States Preventable Vaccines Sales Volume Forecast by Type ( 2019-2025)
    11.3 United States Preventable Vaccines Sales Volume Forecast by Application ( 2019-2025)
    11.4 United States Preventable Vaccines Sales Volume Forecast by Region ( 2019-2025)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer